Cargando…
Colorectal cancer patients with different C-reactive protein levels and 5-year survival times can be differentiated with quantitative serum proteomics
Over 1.4 million people are diagnosed with colorectal cancer (CRC) each year, making it the third most common cancer in the world. Increased screening and therapeutic modalities including improved combination treatments have reduced CRC mortality, although incidence and mortality rates are still inc...
Autores principales: | Holm, Matilda, Saraswat, Mayank, Joenväärä, Sakari, Ristimäki, Ari, Haglund, Caj, Renkonen, Risto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5891022/ https://www.ncbi.nlm.nih.gov/pubmed/29630649 http://dx.doi.org/10.1371/journal.pone.0195354 |
Ejemplares similares
-
Plasma protein expression differs between colorectal cancer patients depending on primary tumor location
por: Holm, Matilda, et al.
Publicado: (2020) -
Identification of several plasma proteins whose levels in colorectal cancer patients differ depending on outcome
por: Holm, Matilda, et al.
Publicado: (2019) -
Comparative proteomic profiling of the serum differentiates pancreatic cancer from chronic pancreatitis
por: Saraswat, Mayank, et al.
Publicado: (2017) -
Quantitative bile and serum proteomics for the screening and differential diagnosis of primary sclerosing cholangitis
por: Holm, Matilda, et al.
Publicado: (2022) -
Oral squamous cell carcinoma patients can be differentiated from healthy individuals with label-free serum proteomics
por: Saraswat, Mayank, et al.
Publicado: (2017)